Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaisa Tasanen

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
The Journal of Investigative Dermatology|March 25, 2019
Gliptin-Associated Bullous Pemphigoid: A Valuable Model of the Mechanism of Breakdown of Immune Tolerance against BP180Wataru Nishie, Kaisa Tasanen
Dermatologic Clinics|May 8, 2010
Epidermolysis bullosa care in ScandinaviaAnders Vahlquist, Kaisa Tasanen
Frontiers in Immunology|July 6, 2019
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous PemphigoidKaisa Tasanen, Outi Varpuluoma, Wataru Nishie
Orphanet Journal of Rare Diseases|September 3, 2014
Gestational pemphigoidLaura Huilaja, Kaarin Mäkikallio, Kaisa Tasanen
International Journal of Molecular Sciences|November 27, 2021
BP180/Collagen XVII: A Molecular ViewJussi Tuusa, Nina Kokkonen, Kaisa Tasanen
Duodecim; Laaketieteellinen Aikakauskirja|June 1, 2013
[Gestational pemphigoid]Laura Huilaja, Kaarin Mäkikallio, Kaisa Tasanen
Duodecim; Laaketieteellinen Aikakauskirja|October 22, 2015
[Bullous pemphigoid--a cause of itching of the skin with increasing incidence]Laura Huilaja, Anna-Kaisa Försti, Kaisa Tasanen
Acta Dermato-Venereologica|November 30, 2022
Risk of Non-cutaneous Cancers in Individuals with Basal Cell Carcinoma: A Population-based Cohort StudyHanna Kuru, Jari Jokelainen, Kaisa Tasanen, et al.
Dermatology (Basel, Switzerland)|November 28, 2013
Allergic contact dermatitis from buprenorphine and oral tolerance to other opioid derivatives in three patientsLaura Huilaja, Riitta Riekki, Aila Immonen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|December 5, 2017
How to identify DRESS, drug reaction with eosinophilia and systemic symptoms?Piia Sarajärvi, Minna Kubin, Kaisa Tasanen, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Investigative Dermatology|March 25, 2019
Gliptin-Associated Bullous Pemphigoid: A Valuable Model of the Mechanism of Breakdown of Immune Tolerance against BP180Wataru Nishie, Kaisa Tasanen
Dermatologic Clinics|May 8, 2010
Epidermolysis bullosa care in ScandinaviaAnders Vahlquist, Kaisa Tasanen
Frontiers in Immunology|July 6, 2019
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous PemphigoidKaisa Tasanen, Outi Varpuluoma, Wataru Nishie
Orphanet Journal of Rare Diseases|September 3, 2014
Gestational pemphigoidLaura Huilaja, Kaarin Mäkikallio, Kaisa Tasanen
International Journal of Molecular Sciences|November 27, 2021
BP180/Collagen XVII: A Molecular ViewJussi Tuusa, Nina Kokkonen, Kaisa Tasanen
Duodecim; Laaketieteellinen Aikakauskirja|June 1, 2013
[Gestational pemphigoid]Laura Huilaja, Kaarin Mäkikallio, Kaisa Tasanen
Duodecim; Laaketieteellinen Aikakauskirja|October 22, 2015
[Bullous pemphigoid--a cause of itching of the skin with increasing incidence]Laura Huilaja, Anna-Kaisa Försti, Kaisa Tasanen
Acta Dermato-Venereologica|November 30, 2022
Risk of Non-cutaneous Cancers in Individuals with Basal Cell Carcinoma: A Population-based Cohort StudyHanna Kuru, Jari Jokelainen, Kaisa Tasanen, et al.
Dermatology (Basel, Switzerland)|November 28, 2013
Allergic contact dermatitis from buprenorphine and oral tolerance to other opioid derivatives in three patientsLaura Huilaja, Riitta Riekki, Aila Immonen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|December 5, 2017
How to identify DRESS, drug reaction with eosinophilia and systemic symptoms?Piia Sarajärvi, Minna Kubin, Kaisa Tasanen, et al.
Pageof 10